PRFX
Price
$1.35
Change
-$0.07 (-4.93%)
Updated
Aug 15 closing price
Capitalization
2.72M
One day until earnings call
ZTS
Price
$154.11
Change
+$1.05 (+0.69%)
Updated
Aug 15 closing price
Capitalization
68.3B
74 days until earnings call
Interact to see
Advertisement

PRFX vs ZTS

Header iconPRFX vs ZTS Comparison
Open Charts PRFX vs ZTSBanner chart's image
PainReform
Price$1.35
Change-$0.07 (-4.93%)
Volume$75.65K
Capitalization2.72M
ZOETIS
Price$154.11
Change+$1.05 (+0.69%)
Volume$3.71M
Capitalization68.3B
PRFX vs ZTS Comparison Chart in %
Loading...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRFX vs. ZTS commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRFX is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (PRFX: $1.35 vs. ZTS: $154.11)
Brand notoriety: PRFX: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PRFX: 39% vs. ZTS: 115%
Market capitalization -- PRFX: $2.72M vs. ZTS: $68.3B
PRFX [@Pharmaceuticals: Generic] is valued at $2.72M. ZTS’s [@Pharmaceuticals: Generic] market capitalization is $68.3B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRFX’s FA Score shows that 0 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • PRFX’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRFX’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 6 bullish TA indicator(s).

  • PRFX’s TA Score: 5 bullish, 3 bearish.
  • ZTS’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than PRFX.

Price Growth

PRFX (@Pharmaceuticals: Generic) experienced а +1.50% price change this week, while ZTS (@Pharmaceuticals: Generic) price change was +4.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

PRFX is expected to report earnings on Aug 18, 2025.

ZTS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($68.3B) has a higher market cap than PRFX($2.72M). ZTS YTD gains are higher at: -4.489 vs. PRFX (-59.762). PRFX has less debt than ZTS: PRFX (59K) vs ZTS (6.75B).
PRFXZTSPRFX / ZTS
Capitalization2.72M68.3B0%
EBITDAN/AN/A-
Gain YTD-59.762-4.4891,331%
P/E RatioN/A26.52-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt59K6.75B0%
FUNDAMENTALS RATINGS
ZTS: Fundamental Ratings
ZTS
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
19
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRFXZTS
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
53%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
55%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
58%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 3 days ago
56%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 18 days ago
56%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
66%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ECC6.710.05
+0.75%
Eagle Point Credit Company
AJAN27.320.01
+0.02%
Innovator Equity DefinedPrtETF-2YTJa2026
VCSH79.580.01
+0.01%
Vanguard Short-Term Corporate Bond ETF
XMAY33.80-0.03
-0.09%
FT Vest US Eq Enh & Mod Buf ETF-May
EMHC24.92-0.07
-0.28%
SPDR® Bloomberg EM USD Bd ETF

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and BHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and BHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
-4.93%
BHC - PRFX
26%
Poorly correlated
+11.05%
AMRX - PRFX
24%
Poorly correlated
+0.64%
EVOK - PRFX
24%
Poorly correlated
-0.39%
ZTS - PRFX
22%
Poorly correlated
+0.69%
PBH - PRFX
21%
Poorly correlated
+0.60%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.69%
ELAN - ZTS
46%
Loosely correlated
-0.22%
VTRS - ZTS
45%
Loosely correlated
-0.75%
PAHC - ZTS
44%
Loosely correlated
+0.33%
HLN - ZTS
38%
Loosely correlated
+0.09%
AMRX - ZTS
38%
Loosely correlated
+0.64%
More